|Home PageMedicinesGaviscon Advance|
Gaviscon Advance From £5.41
Treatment of symptoms of gastro-oesophageal reflux such as acid regurgitation, heartburn and indigestion (related to reflux), for example, following meals, or during pregnancy, or in patients with symptoms related to reflux oesophagitis.
Adults and children 12 years and over: 5-10 ml after meals and at bedtime.
Children under 12 years: Should be given only on medical advice.
Elderly: No dose modification is required for this age group.
If symptoms do not improve after seven days, the clinical situation should be reviewed
Shake well before use. Check that the cap seal is unbroken before first taking the product.
When not to use:
This medicinal product is contraindicated in patients with known or suspected hypersensitivity to the active substances or to any of the excipients.
Precautions for use:
Each 10 ml dose has a sodium content of 106 mg (4.6 mmol) and a potassium content of 78 mg (2.0 mmol). This should be taken into account when a highly restricted salt diet is recommended, e.g. in some cases of congestive cardiac failure and renal impairment or when taking drugs which can increase plasma potassium levels.
Each 10 ml contains 200 mg (2.0 mmol) of calcium carbonate. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis and recurrent calcium containing renal calculi.
There is a possibility of reduced efficacy in patients with very low levels of gastric acid.
Treatment of children younger than 12 years of age is not generally recommended, except on medical advice.
There are 3 reviews with an average rating of 4.33
Anonymous from FinlandOwner26 April 2017 18:42
It was so good wrapped up that i had difficulties to open it(: Thats very good compared to another pharmacyshop i used to place order earlier in U.K. So thanks again. Will order again.
Myrna from CanadaOwner17 December 2013 23:02
Not very pleasant tasting , but I feel it is working. I have only been taking it for less than two weeks but I can tell that it is helping.